timothy sykes logo
RKLB Stock Rockets As Wall Street Hikes Price Targets Thumbnail

RKLB Stock Rockets As Wall Street Hikes Price Targets

JACK KELLOGGUPDATED MAY. 18, 2026, 9:20 AM ET
Reviewed by Tim Sykesand Fact-checked by Ellis Hobbs

Rocket Lab Corporation stocks have been trading up by 5.38 percent following strong investor optimism over its latest launch contracts.

Candlestick Chart

Live Update At 09:19:35 EDT: On Monday, May 18, 2026 Rocket Lab Corporation stock [NASDAQ: RKLB] is trending up by 5.38%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

RKLB has been trading like a high‑beta rocket on a steep climb. From 2026/04/23 to 2026/05/15, Rocket Lab stock ripped from the low‑$80s to mid‑$120s, with a spike to $133.18 on 2026/05/14 before a modest pullback to $124.77 on 2026/05/15. That’s a huge move in a few weeks, and traders need to respect that volatility.

Intraday, the 5‑minute tape around $129–$132 shows tight consolidation with small candles and higher lows, a classic digestion zone after a parabolic run. RKLB is holding well above prior breakout levels near $100–$105, telling traders that dip‑buyers are still in control for now.

Fundamentally, Rocket Lab delivered Q1 revenue of about $200.3M, with full‑year revenue running at roughly $601.8M and a strong 34.4% gross margin. Profitability is not here yet: EBIT margin is around ‑33.6% and net margin near ‑33%. Cash flow from operations was negative and free cash flow around ‑$77.4M, but RKLB ended the quarter with $1.21B in cash and a light debt load, reflected in a 0.15 debt‑to‑equity ratio and a current ratio of 4.1. For traders, that means a classic high‑growth, high‑valuation story with runway — but also sharp downside risk if sentiment turns.

Why Traders Are Watching RKLB Right Now

Rocket Lab is turning into one of the most watched tickers in the space sector, and the news flow explains why. CFRA reaffirmed a Strong Buy on RKLB, jacked its 12‑month target to $140, and highlighted a record backlog of over 70 missions plus strong Neutron pre‑launch bookings, including the biggest contract in Rocket Lab history. That kind of language from a major research shop pulls momentum traders straight to the chart.

Deutsche Bank followed up by raising its RKLB price target from $73 to $120 and sticking with a Buy after earnings, citing rising demand across Rocket Lab’s services. Clear Street also raised its target to $98 after record Q1 revenue beat expectations by about 5%, driven by both launch and space systems. Put together, you have multiple firms leaning bullish on RKLB at the same time, all off the back of execution and visibility, not just hype.

On the demand side, Craig‑Hallum upgraded RKLB from Hold to Buy after a strong quarterly beat and above‑consensus Q2 outlook. The firm pointed to booming hypersonics, a $190M DoD HASTE contract, growing medium‑lift demand, and strength in Space Systems. That’s important: Rocket Lab is not just a small‑sat launcher anymore. The Anduril deal for $30M of HASTE hypersonic test flights — plus the earlier 20‑launch HASTE block buy — means hypersonic test missions now make up almost one‑third of RKLB’s 70+ launch backlog.

Strategically, RKLB’s plan to acquire Motiv Space Systems adds Mars‑proven robotics and precision mechanisms, tightening its grip on high‑value satellite and exploration work. New Street Research even initiated coverage with a Buy, arguing Rocket Lab captures less than 1% of the broader space economy despite being the only scaled Western launch and space platform outside SpaceX. That kind of setup is exactly what momentum‑focused traders hunt: rising numbers, strong contracts, and a narrative that Wall Street is only now starting to price in.

More Breaking News

Conclusion

For active traders, RKLB now sits at the crossroads of fast growth, defense spending, and speculative momentum. Q2 revenue guidance of $225M–$240M, well above the prior $205.05M consensus, shows Rocket Lab management is not sandbagging. Combine that with contracts like the $30M Anduril HASTE deal, the $190M DoD HASTE award, and U.S. Space Force work on the Space Based Interceptor program, and RKLB is stitching itself into the national security fabric. That usually means longer‑term, higher‑quality revenue, even if the path is bumpy.

At the same time, the tape shows real volatility. RKLB has seen double‑digit daily moves, including an 11.2% surge followed by a 2.2% premarket dip, plus a 7% premarket rebound on Wallstreetbets chatter. Insider selling, such as Alexander Slusky’s $11.8M sale on 2026/05/12, reminds traders that some holders are locking in gains after the run.

This is where discipline matters. The valuation is rich — price‑to‑sales above 100 and negative earnings — so RKLB is a momentum‑and‑story trade, not a value play. As Tim Sykes likes to say, “The market doesn’t owe you anything — your only job is to cut losses quickly and protect your buying power.” As millionaire penny stock trader and teacher Tim Sykes says, “There is always another play around the corner; don’t chase just because you feel FOMO.”. For Rocket Lab, that means riding the trend when the chart and news align, but always having a clear risk level, because high‑flyers can fall back to earth just as fast as they launch.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



How much has this post helped you?


Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”